An important Australian study is very promising to help with Type 1 diabetes


Australian researchers from University of Queensland and Mater may be a step closer to preventing Type 1 diabetes. They discovered a crucial protein that could prevent the autoimmune disease. “We found boosting the regulatory T-cells using sRAGE in the pancreas, pancreatic lymph nodes and spleen prevented diabetes, and also resulted in better insulin expression and function,” Mater Researcher, Dr Sherman Leung said. The laboratory tests in human cell models showed the sRAGE treatment increased regulatory T-cells at important sites in the body critical for Type 1 diabetes development. Type 1 diabetes affects about 12 in every 100,000 Australians, with an average of about seven new cases diagnosed per day. Unlike type 2 diabetes, which is generated by lifestyle factors such as obesity and lack of exercise, type 1 diabetes is an autoimmune condition that often manifests in early childhood.Individuals with Type 1 diabetes are at greater risk of premature death from disease complications including heart attacks.


Lead researcher Professor Josephine Forbes said the discovery was a world first, and was very exciting because it seemed to completely shut off the immune process which causes type 1 diabetes.Researchers are focusing on developing some delivery method such as tablets or liquid which would be easy to give to young children who are either developing or have just developed the disease.